Literature DB >> 33051040

Diarrhea hospitalization costs among children <5 years old in Madagascar.

Eleanor Burnett1, Vonintsoa Lalaina Rahajamanana2, Julia Liliane Raboba2, Goitom Weldegebriel3, Yolande Vuo Masembe4, Jason M Mwenda5, Umesh D Parashar6, Jacqueline E Tate6, Annick Lalaina Robinson2.   

Abstract

BACKGROUND: Following a recommendation by the World Health Organization, Madagascar introduced rotavirus vaccine in 2014. Though national rotavirus vaccine coverage has remained <80%, rotavirus hospitalizations declined by 78%. Gavi, the Vaccine Alliance, has provided financial support for rotavirus vaccine, however the Malagasy government has increasing responsibility for the financial cost.
METHODS: In this evaluation, we describe the direct medical, direct non-medical, and indirect cost of illness due to diarrhea among children <5 years old at a public pediatric referral hospital. A 3-part structured questionnaire was administered during and following the hospitalization and the child's hospital record was reviewed.
RESULTS: In total, 96 children were included in this analysis. The median total cost of the illness was $156.00 (IQR: 104.00, 210.86) and the median direct medical cost was $107.22. Service delivery costs represented a median of 44% of the inpatient costs; medications and diagnostic tests represented a median of 28% and 20% of the total costs of the hospitalization, respectively. The median percentage of the total illness costs paid by the household was 67%. Among households with income of <$61/month, the median costs of the illness paid by the household were $78.55, representing a median of 168% of the household's monthly expenses. Among households earning >$303/month, the median costs paid by the household were $147.30, representing a median of 53% of the household's monthly expenses. Among all household income levels, caregivers commonly paid these bills from savings, borrowed money, and donations.
CONCLUSIONS: Our findings will be useful in assessing the cost-effectiveness of rotavirus vaccine by decisionmakers. These results may also help hospital administrators and healthcare providers better understand the financial constraints of families. Published by Elsevier Ltd.

Entities:  

Keywords:  Diarrhea; Madagascar; Rotavirus

Mesh:

Substances:

Year:  2020        PMID: 33051040      PMCID: PMC8095251          DOI: 10.1016/j.vaccine.2020.09.082

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Authors:  Deborah E Atherly; Kristen D C Lewis; Jacqueline Tate; Umesh D Parashar; Richard D Rheingans
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

2.  Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.

Authors:  Charles Sigei; John Odaga; Mercy Mvundura; Yvette Madrid; Andrew David Clark
Journal:  Vaccine       Date:  2015-05-07       Impact factor: 3.641

3.  Rotavirus vaccines. WHO position paper – January 2013.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-02-01

4.  Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.

Authors:  V L Rahajamanana; J L Raboba; A Rakotozanany; N J Razafindraibe; E J P R Andriatahirintsoa; A C Razafindrakoto; S A Mioramalala; C Razaiarimanga; G G Weldegebriel; E Burnett; J M Mwenda; M Seheri; M J Mphahlele; A L Robinson
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

Review 5.  Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.

Authors:  Minesh P Shah; Jacqueline E Tate; Jason M Mwenda; A Duncan Steele; Umesh D Parashar
Journal:  Expert Rev Vaccines       Date:  2017-09-04       Impact factor: 5.217

6.  Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study.

Authors:  Frédéric Debellut; Andrew Clark; Clint Pecenka; Jacqueline Tate; Ranju Baral; Colin Sanderson; Umesh Parashar; Laura Kallen; Deborah Atherly
Journal:  Lancet Glob Health       Date:  2019-12       Impact factor: 26.763

7.  The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.

Authors:  Fidele Ngabo; Mercy Mvundura; Lauren Gazley; Maurice Gatera; Celse Rugambwa; Eugene Kayonga; Yvette Tuyishime; Jeanne Niyibaho; Jason M Mwenda; Philippe Donnen; Philippe Lepage; Agnes Binagwaho; Deborah Atherly
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

8.  Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.

Authors:  Ranju Baral; Justice Nonvignon; Frédéric Debellut; Samuel Agyei Agyemang; Andrew Clark; Clint Pecenka
Journal:  BMC Public Health       Date:  2020-05-05       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.